![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, an... Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. Show more
– Preliminary Phase 2 SOLSTICE trial data reinforce the potential of both regimens to be transformative treatments in an area of high unmet medical need – – Conference call scheduled for June 5...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.01 | -17.0918367347 | 11.76 | 11.83 | 9.62 | 1485036 | 10.82489845 | CS |
4 | -0.19 | -1.91146881288 | 9.94 | 13.09 | 9.6 | 1200872 | 11.0506206 | CS |
12 | -0.34 | -3.36967294351 | 10.09 | 13.09 | 7.61 | 974899 | 9.94048723 | CS |
26 | -0.53 | -5.15564202335 | 10.28 | 13.09 | 7.61 | 1080043 | 10.08126685 | CS |
52 | -16.75 | -63.2075471698 | 26.5 | 26.74 | 7.61 | 1220626 | 11.34574782 | CS |
156 | -35.25 | -78.3333333333 | 45 | 58 | 7.61 | 1166650 | 23.95245429 | CS |
260 | -6.4 | -39.6284829721 | 16.15 | 141.01 | 7.61 | 1132302 | 30.17483153 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions